The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy

被引:1
|
作者
Wang, Yongmei [1 ]
Li, Saisai [2 ]
Wang, Wenqin [3 ]
机构
[1] Qingdao Univ, Breast Dis Ctr, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[2] Qingdao Univ, Dept Hematol, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[3] Shandong Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
UPS; TIME; immune cells; immunotherapy; cancer; MHC CLASS-II; NF-KAPPA-B; DOWN-REGULATE PD-L1; T-CELLS; DENDRITIC CELLS; CANCER-CELLS; LIGASE KPC1; IMMUNOTHERAPY; EXPRESSION; COSTIMULATION;
D O I
10.3389/fimmu.2024.1436174
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ubiquitin-proteasome system (UPS) plays a crucial role in modulating the proliferation, activation, and normal functioning of immune cells through the regulation of protein degradation and function. By influencing the expression of immune checkpoint-associated proteins, the UPS modulates T cell-mediated anti-tumor immune responses and can potentially facilitate the immune escape of tumor cells. Additionally, the UPS contributes to the remodeling of the tumor immunosuppressive microenvironment (TIME) by regulating B cells, dendritic cells (DCs), macrophages, and Treg cells. Targeting the UPS in conjunction with immune checkpoint-associated proteins, and combining these with other therapeutic approaches, may significantly enhance the efficacy of combination therapies and pave the way for novel cancer treatment strategies. In this review, we first summarize the composition and alterations of the TIME, with a particular emphasis on the role of the UPS in TIME and its interactions with various immune cell types. Finally, we explore the potential of combining UPS-targeted therapies with immunotherapy to substantially improve the effectiveness of immunotherapy and enhance patient survival outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Role of the ubiquitin-proteasome system on macrophages in the tumor microenvironment
    Xiao, Yue
    Liu, Ruiqian
    Li, Na
    Li, Yong
    Huang, Xuan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2024, 239 (02)
  • [2] Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression
    Huang, Yulan
    Gao, Yuan
    Lin, Zhenghong
    Miao, Hongming
    GENES & DISEASES, 2025, 12 (02)
  • [3] The Ubiquitin-Proteasome System in Immune Cells
    cetin, Gonca
    Klafack, Sandro
    Studencka-Turski, Maja
    Kruger, Elke
    Ebstein, Frederic
    BIOMOLECULES, 2021, 11 (01) : 1 - 23
  • [4] The Ubiquitin-Proteasome System in Tumor Metabolism
    Wang, Jie
    Xiang, Yuandi
    Fan, Mengqi
    Fang, Shizhen
    Hua, Qingquan
    CANCERS, 2023, 15 (08)
  • [5] Ubiquitin-proteasome system - The ubiquitin-proteasome system: past, present and future
    Hilt, W
    Wolf, DH
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (13) : 1545 - 1545
  • [6] The ubiquitin-proteasome system
    Dipankar Nandi
    Pankaj Tahiliani
    Anujith Kumar
    Dilip Chandu
    Journal of Biosciences, 2006, 31 : 137 - 155
  • [7] Targeting the ubiquitin-proteasome system for cancer therapy
    Yang, Yili
    Kitagaki, Jirouta
    Wang, Honghe
    Hou, De-Xing
    Perantoni, Alan O.
    CANCER SCIENCE, 2009, 100 (01) : 24 - 28
  • [8] The ubiquitin-proteasome system
    Nandi, D
    Tahiliani, P
    Kumar, A
    Chandu, D
    JOURNAL OF BIOSCIENCES, 2006, 31 (01) : 137 - 155
  • [9] Targeting the ubiquitin-proteasome system for cancer therapy
    Shen, Min
    Schmitt, Sara
    Buac, Daniela
    Dou, Q. Ping
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (09) : 1091 - 1108
  • [10] Ubiquitin-proteasome systemThe ubiquitin-proteasome system: past, present and future
    W. Hilt
    D. H. Wolf
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 1545 - 1545